Cancer Letters
Volume 226, Issue 1 , Pages 65-75, 8 August 2005

Cytotoxicity of three cycloartane triterpenoids from Cimicifuga dahurica

  • Ze Tian

      Affiliations

    • Institute of Medicinal Plant, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100094, People's Republic of China
    • Department of Biology and Chemistry, City University of Hong Kong, Hong Kong, People's Republic of China
    • Corresponding Author InformationCorresponding author. Address: Institute of Medicinal Plant, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100094, People's Republic of China. Tel.: +86 10 62894597.
  • ,
  • Mengsu Yang

      Affiliations

    • Department of Biology and Chemistry, City University of Hong Kong, Hong Kong, People's Republic of China
  • ,
  • Feng Huang

      Affiliations

    • Institute of Medicinal Plant, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100094, People's Republic of China
  • ,
  • Keguo Li

      Affiliations

    • Institute of Zoology, Chinese Academy of Sciences, People's Republic of China
  • ,
  • Jianyong Si

      Affiliations

    • Institute of Medicinal Plant, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100094, People's Republic of China
  • ,
  • Lin Shi

      Affiliations

    • Department of Biology and Chemistry, City University of Hong Kong, Hong Kong, People's Republic of China
  • ,
  • Sibao Chen

      Affiliations

    • Institute of Medicinal Plant, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100094, People's Republic of China
    • Department of Application of Biology and Chemistry Technology, The Hong Kong Polytechnic University, Hong Kong, People's Republic of China
  • ,
  • Peigen Xiao

      Affiliations

    • Institute of Medicinal Plant, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100094, People's Republic of China

Received 7 May 2004; received in revised form 5 October 2004; accepted 1 November 2004.

Abstract 

We first investigated the cytotoxicity of three cycloartane triterpenoids isolated from the aerial part of C. dahurica. Their cytotoxic activity was investigated on several cancer cell lines including solid tumor (HepG2), blood tumor (HL-60), drug resistant tumor (R-HepG2) and primary cultured normal mouse and rat hepatocytes in order to find efficient anti-tumor agents against both parental and drug-resistant tumor with reduced toxicity. Evident cytotoxicity of these compounds on all tested neoplastic cell lines revealed that they are efficient on both drug-resistant tumor and parental tumor. Furthermore, they all showed relatively selective cytotoxicity on cancerous cells based on the higher IC50 values of them on normal cells than that on tumor cells. Morphological observation and cell cycle analysis were employed to elucidate the cytotoxicity of the tested compounds. They brought out similar apoptotic morphological changes and G2/M cell cycle arrest in HepG2, R-HepG2 and HL-60 cells. Moreover, they suppressed the expression of cdc2 and COX-2 protein. These results imply that the three compounds possess potential anti-tumor activities and they exert their cytotoxicity via apoptosis and G2/M arrest. In addition, inhibition of cdc2 protein expression correlates with mechanism of G2/M arrest.

Keywords: Cycloartane triterpenoids, Cytotoxicity, Apoptosis, Cell cycle, cdc 2, Cyclooxygenase-2

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0304-3835(04)00876-6

doi:10.1016/j.canlet.2004.11.019

Cancer Letters
Volume 226, Issue 1 , Pages 65-75, 8 August 2005